EAM
STLN

Empery Asset Management’s Starling Oncology STLN Stock Holding History

Empery Asset Management’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-70,733
Closed -$504K – 82
2022
Q1 		$504K Sell
70,733
-129,267
-65% -$872K 2.37% 13
2021
Q4 		$1.95M Buy
+200,000
New +$1.78M 4.07% 10

Other funds holding STLN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Empery Asset Management's STLN Position: Q2 2022 in Review

Empery Asset Management sold out of Starling Oncology (STLN) in Q2 2022, closing a stake of 70,733 shares — an estimated $504K sold.

Empery Asset Management first reported a position in STLN in Q4 2021 and held it in 2 quarters. The position peaked at $1.95M in Q4 2021. 36 funds tracked by Wall St. Rank hold STLN as of Q2 2022.

  • Empery Asset Management reported no remaining Starling Oncology position as of Q2 2022 after selling out during the quarter.
  • Empery Asset Management sold 70,733 Starling Oncology shares in Q2 2022, an estimated $504K.
  • Empery Asset Management first reported a position in Starling Oncology in Q4 2021 and held it in 2 quarters.
  • Empery Asset Management's Starling Oncology position peaked at $1.95M in Q4 2021.
  • 36 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2022.

Based on Empery Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.